An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial

The purpose of this extension study is to provide venetoclax and obtain long-term safety data for subjects who continue to tolerate and derive benefit from receiving venetoclax in ongoing studies.

Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT03844048.

Trial PhasePhase III

Trial Typetreatment

Lead OrganizationAbbvie

• Primary IDM19-388
• Secondary IDsNCI-2019-05883, 2018-004356-38, 2022-501522-38-00
• ClinicalTrials.gov IDNCT03844048